Keyphrases
AKT1
20%
Appropriate Treatment
20%
Clinical Application
20%
Clinical Benefit
60%
Complete Response
20%
Decision Tree
20%
Expression Level
20%
Fibroblast Growth Factor Receptor 2 (FGFR2)
20%
Gene mutation
20%
Histopathological Data
20%
Hypoxia-inducible factor-1α (HIF-1α)
40%
Inhibitor Response
20%
Interleukin-8
20%
ISUP Grade
20%
Lymph Node Metastasis
20%
Metastatic Renal Cell Carcinoma (mRCC)
100%
MicroRNA
20%
MiR-421
20%
MiRNA Expression
20%
Necrosis
40%
Partial Response
20%
PD-L2
20%
Platelet-derived Growth Factor Receptor (PDGFR)
20%
Programmed Death-ligand 1 (PD-L1)
20%
Progressive Disease
20%
Protein Expression Level
20%
Receptor-targeted Therapy
20%
Sarcomatoid
20%
Sarcomatoid Change
20%
Stable Disease
40%
Support Vector Machine
40%
Thrombocytosis
20%
Tumor Size
20%
Tyrosine Kinase Inhibitor
20%
Tyrosine Kinase Inhibitor Treatment
20%
Vascular Endothelial Growth Factor Receptor (VEGFR)
20%
Vascular Endothelial Growth Factor Receptor Inhibitor
100%
Medicine and Dentistry
Diseases
33%
Fibroblast Growth Factor Receptor 2
16%
Gene Mutation
16%
Kidney Metastasis
100%
Lymph Node Metastasis
16%
microRNA
33%
Necrosis
33%
Neoplasm
16%
Programmed Death-Ligand 1
16%
Progressive Disease
16%
Protein Expression
16%
Protein Tyrosine Kinase
100%
Sarcomatoid
33%
Targeted Therapy
16%
Thrombocytosis
16%
Tyrosine-Kinase Inhibitor
100%
Vasculotropin Receptor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
50%
Fibroblast Growth Factor Receptor 2
16%
Kidney Metastasis
100%
Lymph Node Metastasis
16%
microRNA
33%
Necrosis
33%
Neoplasm
16%
Protein Tyrosine Kinase
100%
Protein Tyrosine Kinase Inhibitor
100%
Thrombocytosis
16%
Vasculotropin Receptor
100%
Biochemistry, Genetics and Molecular Biology
Decision Tree
16%
Fibroblast Growth Factor Receptor 2
16%
Gene Mutation
16%
Interleukin 8
16%
MicroRNA
33%
PD-L1
16%
Protein Expression Level
16%
Receptor Tyrosine Kinase Inhibitors
100%
Support Vector Machine
33%
Targeted Therapy
16%
Thrombocytosis
16%
Tumor Volume
16%
Tyrosine Kinase Inhibitor
16%
VEGF Receptor
100%